Quality Indicator Repository

≥70% of patients reporting yes they know what heart pills they should be taking post-program, in program completers that have coverage for medication

The indicator shows the proportion of responses to the following question: Can you electronically exchange the following with any doctors outside your practice? Do not include fax or regular email: Lists of all medications taken by an individual patient; Response options: (1) Yes, (2) No, (3) Not sure

Percent of enrolled patients 18 years of age and over with congestive heart failure who have been reviewed for exemptions from using ACE Inhibitors / ARB (LVEF=>40% and/or any other) or who are prescribed ACE inhibitors or ARB in the last 12 months.

Proportion of patients who are diagnosed with mild to moderate Alzheimer's disease and have acetylcholinesterase inhibitor (AChEI)prescribed/recommended

Percentage of people who are long-term users of glucose regulating medication with concomitant use of one or more prescriptions of cholesterol lowering medication.

Documents whether provider has adopted a qualified e-Prescribing system and the extent of use in the ambulatory setting.

The percentage of patients who selected the most positive response option to the survey question: Did a health professional in the hospital tell you about medication side effects to watch for? [if patient was given or prescribed new medication to take at home]

Percentage of patients aged 2 years and older with a diagnosis of allergic rhinitis who are prescribed or recommended intranasal corticosteroids (INS) or non-sedating oral antihistamines

This measure assesses the percentage of patients who received a least 180 treatment days of medication, and had a test to monitor for the use of that medication. The measure is a composite of two sub-indicators that evaluate angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARB), and diuretics (serum potassium and a serum creatinine therapeutic monitoring test) in the measurement year.

The percentage of individuals 18 years and older who are prescribed long-term opioid therapy and have not received a drug test at least once during the measurement year.

The percentage of individuals 18 years of age and older who are on long-term opioid therapy and have not received a drug test at least once during the measurement year.

Prevalence of antianxiety / hypnotic medication use.

Prevalence of antianxiety or hypnotic drug use.

Ischaemic stroke patients with atrial fibrillation/flutter who are prescribed or continuing to take anticoagulation therapy at hospital discharge.

The percentage of members 18 years of age and older who were treated with antidepressant medication, had a diagnosis of major depression and who remained on an antidepressant medication treatment. Two rates are reported. 1. Effective Acute Phase Treatment. The percentage of members who remained on an antidepressant medication for at least 84 days (12 weeks). 2. Effective Continuation Phase Treatment. The percentage of members who remained on an antidepressant medication for at least 180 days (6 months).

Prevalence of antipsychotic drug use in the absence of psychotic and related condition.

Percentage of long-term care home residents without psychosis on antipsychotics in the last 7 days.

Proportion of residents dispensed an antipsychotic.

Proportion of home care recipients who were dispensed an antipsychotic.

Prevalence of antipsychotic use in absence of indication.

The percent of Part D beneficiaries 65 years or older with a diagnosis of or prescriptions for dementia, who received at least one prescription and greater than 30 total days supply for any antipsychotic medication, AND who did not have a diagnosis for schizophrenia, bipolar disorder, Huntington's disease, or Tourette's Syndrome.

Ischaemic stroke patients administered antithrombotic therapy by the end of hospital day 2.